GlassScriptPhysician profile
Clinton A Marlar
NPI 1528115409
$2,551.62
in general payments reported to CMS, 2019-2025
22 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2021: $253 · 2022: $449 · 2023: $942 · 2024: $285 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,569.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $850.62 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $524.81 | 2022-2025 | Phasix Mesh, Channel Drain |
| Becton, Dickinson and Company | $182.17 | 2023 | |
| Stryker Corporation | $121.14 | 2023 | Aequalis Ascend Flex |
| Conmed Corporation | $97.88 | 2019-2024 | Airseal |
| Ethicon US, LLC | $83.64 | 2021-2025 | Prolene, Ethicon, Dermabond Prineo |
| W. L. Gore & Associates, INC. | $77.40 | 2024-2025 | Gore Synecor Biomaterial |
| Tela Bio, INC. | $73.20 | 2019-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $71.36 | 2024-2025 | Transorb, Ligasure |
| Lemaitre Vascular, INC. | $67.08 | 2019 | |
| Olympus America INC. | $56.94 | 2022-2023 | |
| Acera Surgical, INC. | $49.57 | 2023-2025 | Restrata Wound Matrix |
| Innovation Technologies INC | $48.47 | 2025 | Irrisept |
| Solventum Corporation | $44.95 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena, Activ.A.C. |
| Endogastric Solutions, INC | $37.32 | 2023 | Esophyx |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuros Medical, INC. | $36.79 | 2025 | Altius |
| Kerecis Limited | $35.46 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Microline Surgical INC | $31.22 | 2025 | |
| Janssen Pharmaceuticals, INC | $20.14 | 2019 | |
| Smith+Nephew, INC. | $14.63 | 2022 | |
| Integra Lifesciences Corporation | $13.87 | 2024 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Boston Scientific Corporation | $12.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Marlar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.